SH PHARMACEU -H-
SH PHARMACEU -H- operates in Diversified Metals & Mining.
SH PHARMACEU -H- (S1R) - Total Liabilities
Latest total liabilities as of September 2024: €140.58 Billion EUR
Based on the latest financial reports, SH PHARMACEU -H- (S1R) has total liabilities worth €140.58 Billion EUR as of September 2024.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
SH PHARMACEU -H- - Total Liabilities Trend (2016–2023)
This chart illustrates how SH PHARMACEU -H-'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
SH PHARMACEU -H- Competitors by Total Liabilities
The table below lists competitors of SH PHARMACEU -H- ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Coil S.A./N.V
PA:ALCOI
|
France | €13.52 Million |
|
XLMedia PLC
PINK:XLMDF
|
USA | $10.67 Million |
|
CFECAPITAL S. De R.L. De C.V
MX:FCFE18
|
Mexico | MX$112.01 Billion |
|
BloomZ Inc. Ordinary Shares
NASDAQ:BLMZ
|
USA | $215.22 Million |
|
TransCanna Holdings Inc
PINK:TCNAF
|
USA | $30.44 Million |
Liability Composition Analysis (2016–2023)
This chart breaks down SH PHARMACEU -H-'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.34 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.98 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.63 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how SH PHARMACEU -H-'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for SH PHARMACEU -H- (2016–2023)
The table below shows the annual total liabilities of SH PHARMACEU -H- from 2016 to 2023.
| Year | Total Liabilities | Change |
|---|---|---|
| 2023-12-31 | €131.65 Billion | +9.58% |
| 2022-12-31 | €120.13 Billion | +15.10% |
| 2021-12-31 | €104.37 Billion | +10.51% |
| 2020-12-31 | €94.44 Billion | +7.76% |
| 2019-12-31 | €87.64 Billion | +8.94% |
| 2018-12-31 | €80.45 Billion | +47.15% |
| 2017-12-31 | €54.67 Billion | +19.08% |
| 2016-12-31 | €45.91 Billion | -- |